Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3513722011 | Abaloparatide (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3513723018 | Abaloparatide | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Abaloparatide (substance) | Is a | Polypeptide (substance) | false | Inferred relationship | Some | ||
| Abaloparatide (substance) | Is a | Parathyroid hormone agent | false | Inferred relationship | Some | ||
| Abaloparatide (substance) | Has disposition (attribute) | Hormone (disposition) | true | Inferred relationship | Some | ||
| Abaloparatide (substance) | Is a | Polypeptide hormone | false | Inferred relationship | Some | ||
| Abaloparatide (substance) | Is a | Parathyroid hormone and/or parathyroid hormone derivative (substance) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing abaloparatide (medicinal product) | Has active ingredient | True | Abaloparatide (substance) | Inferred relationship | Some | 1 |
| Product containing abaloparatide in parenteral dose form (medicinal product form) | Has active ingredient | True | Abaloparatide (substance) | Inferred relationship | Some | 1 |
| Product containing only abaloparatide (medicinal product) | Has active ingredient | True | Abaloparatide (substance) | Inferred relationship | Some | 1 |
| Product containing only abaloparatide in parenteral dose form (medicinal product form) | Has active ingredient | True | Abaloparatide (substance) | Inferred relationship | Some | 1 |
Reference Sets
Belgian subset for AllergyIntolerance, causative agent, drug
FHIR